Prevention of Bloodstream Infections by Use of Daily Chlorhexidine Baths for Patients at a Long-Term Acute Care Hospital
|
|
- Silvester Maximillian Summers
- 7 years ago
- Views:
Transcription
1 infection control and hospital epidemiology november 2009, vol. 30, no. 11 original article Prevention of Bloodstream Infections by Use of Daily Chlorhexidine Baths for Patients at a Long-Term Acute Care Hospital L. Silvia Munoz-Price, MD; Bala Hota, MD, MPH; Alexander Stemer, MD; Robert A. Weinstein, MD objective. To evaluate the effect of bathing patients with 2% chlorhexidine on the rates of central vascular catheter (CVC) associated bloodstream infection (BSI) at a long-term acute care hospital (LTACH). design. Quasi-experimental study setting. A 70-bed LTACH in the greater Chicago area. patients. All consecutive patients admitted to the LTACH during the period from February 2006 to February methods. For patients at the LTACH, daily 2% chlorhexidine baths were instituted during the period from September 2006 until May 2007 (ie, the intervention period). A preintervention period (in which patients were given daily soap-and-water baths) and a postintervention period (in which patients were given daily nonmedicated baths and weekly 2% chlorhexidine baths) were also observed. The rates of CVCassociated BSI and ventilator-associated pneumonia were analyzed for the intervention period and for the pre- and postintervention periods. results. The rates of CVC-associated BSI were 9.5, 3.8, and 6.4 cases per 1,000 CVC-days during the preintervention, intervention, and postintervention periods, respectively. By the end of the intervention period, there was a net reduction of 99% in the CVC-associated BSI rate. No changes were seen in the rates of ventilator-associated pneumonia during the preintervention and intervention periods. conclusion. Daily chlorhexidine baths appeared to be an effective intervention to reduce rates of CVC-associated BSI in an LTACH. Infect Control Hosp Epidemiol 2009; 30: Bloodstream infections (BSIs) constitute one of the most common healthcare-acquired infections in the United States. According to 2002 Centers for Disease Control and Prevention data, a total of 250,000 nosocomial cases of BSI occur each year with a mortality rate as high as 25% and an attributable cost of up to US$56,000 per episode. 1 Most studies of BSI prevention have been conducted in intensive care units 2-4 ; however, during the past decade, we have seen a significant increase in numbers of patients at risk for BSI admitted to long-term acute care hospitals (LTACHs). 5,6 These institutions are different from other long-term care facilities (eg, nursing homes) in that LTACH patients have not only just been discharged from an acute care setting but they still require acute care. Patients admitted to an LTACH often require intravenous antibiotics through central vascular catheters (CVCs), ventilator weaning, or daily wound care and physical therapy. 7 In the past, these patients would have remained in the hospital until the completion of those therapies; however, to decrease the costs of acute care hospitalization, in 1993, Medicare exempted LTACHs from the prospective payment system; this decision was reversed in The average length of stay in LTACHs across the United States, as required by Medicare, is 25 days or longer. The end result is that a high number of moderate to severely ill patients are concentrated in the same institution for longer periods of time than normally would be during acute care hospitalizations. 9 Wolfenden et al 10 previously described an unusually high rate of BSI among patients in LTACHs, comparable to the top 10% rates reported among intensive care units. Chlorhexidine is a topical antiseptic that has been shown to decrease the rates of BSI when used for the daily cleansing of patients in intensive care units. 2 Because of the paucity of studies looking at the prevention of BSIs in LTACHs and the effectiveness of chlorhexidine baths in acute care, we decided to evaluate the effect of bathing patients with 2% chlorhexidine on the rates CVC-associated BSI at an LTACH. methods Our study was performed as an infection control intervention at a 70-bed LTACH in the greater Chicago area. The duration of the study was from February 2006 to February 2008 and From the Medical Specialists, Munster, Indiana (L.S.M.-P., A.S.), and the Department of Medicine, John H. Stroger Jr. Hospital, and Rush University Medical Center, Chicago, Illinois (B.H., R.A.W.). (Present affiliations: Division of Infectious Diseases, University of Miami, and Department of Infection Control, Jackson Memorial Hospital, Miami, Florida [L.S.M.-P.].) Received March 13, 2009; accepted May 20, 2009; electronically published September 14, by The Society for Healthcare Epidemiology of America. All rights reserved X/2009/ $ DOI: /644751
2 1032 infection control and hospital epidemiology november 2009, vol. 30, no. 11 consisted of a baseline preintervention period, an intervention period, and a postintervention period. The preintervention period involved all consecutive patients admitted during the period from February 2006 to August This group of patients received daily soap-and-water baths, per the institution s policy. During the intervention period, daily 2% chlorhexidine baths were given to all consecutive patients admitted to the LTACH during the period from September 2006 to May No other intervention to prevent CVCassociated BSIs was implemented during this time period. CVCs at this institution consist fundamentally of peripherally inserted central catheters. The insertion team is composed of one individual (the same person throughout) contracted by the institution for all insertions of peripherally inserted central catheters. Dressing changes of catheter insertion sites were performed by nursing personnel every 7 days. The postintervention period extended from June 2007 to February This was a heterogeneous, noncontrolled period characterized by the lack of daily chlorhexidine use. During the first 2 months (June July) of this period, the nursing aides bathed patients with baby shampoo most of the time in the belief that soap was better for their patients than was chlorhexidine; the aides decided to use baby shampoo because all other soaps had been removed from the nursing stations. In August 2007, when the infection preventionist realized that there had been this change in bathing technique, chlorhexidine baths were reinstituted for 2 months (August-September). Starting in October 2007, the institution implemented a policy of daily nonmedicated baths (Comfort Baths; Sage Products) and weekly 2% chlorhexidine baths (2% chlorhexidine gluconate cloths; Sage Products) for all patients. Chlorhexidine Preparation and Storage Bulk 4% chlorhexidine (Betasept; Purdue Pharma) was obtained from the pharmacy wholesale supplier. The pharmacy department prepared a 1 : 2 dilution with tap water and stored the solution in disposable 1-gallon plastic containers. All nursing stations were stocked with the final 2% chlorhexidine solution. At admission, each patient s room was supplied with 3 gallons of the 2% chlorhexidine solution, which was restocked as needed. All other soap solutions were removed from the nursing stations and patient rooms. Chlorhexidine Application During the intervention and postintervention periods, 2% chlorhexidine baths up to the jawline, using 3 clean washcloths, were given to all patients. After its application, the solution was allowed to dry without rinsing. All body cavities were spared. During the intervention period, chlorhexidine baths were given on a daily basis; nurses and nursing aides were trained and were evaluated weekly, for the first 2 months of the intervention, on the correct application of the solution. Emphasis was placed on not using additional water during baths unless stool incontinence was present, in which case water was used to clean the soiled area prior to the application of chlorhexidine. Beginning with the fifth month of the postintervention period, chlorhexidine baths were given on a weekly basis; no evaluations of use took place, and no measures of compliance with chlorhexidine bathing procedures were performed. Nursing units were stocked only with moisturizers compatible with chlorhexidine. Patient Data and Statistics The case-mix index, a monthly cumulative acuity index, 11 was provided by the institution. A census of patients who received mechanical ventilation and a CVC was recorded daily by the infection preventionist. Using the Centers for Disease Control and Prevention criteria, the infection preventionist also recorded all cases of CVC-associated BSI and ventilator-associated pneumonia (VAP) and their causative organisms. To examine the effect of bathing patients with chlorhexidine on the incidence of VAP, rates of VAP were assessed from the start of the preintervention period through month 5 of the intervention period; beginning in month 6, a VAP prevention bundle was implemented, 12 and VAP rates subsequent to this implementation were not analyzed for our study. Interrupted time-series analysis was performed using the incidence density of cases of both VAP and CVC-associated BSI, modeled as events divided by device-days. The time period (ie, preintervention, intervention, or postintervention) and the month of the time period were primary covariates of interest. Case-mix indices and ventilator-days were included in the initial multivariable model. Poisson regression was used; variables were eliminated using a backward-selection approach for variables with P values greater than.15. All analyses were performed using SAS, version 9.1 (SAS Institute). results During 24 months, we identified a total of 139 cases of CVCassociated BSI. The average rate of CVC-associated BSI was 9.5 cases per 1,000 CVC-days during the preintervention period, 3.8 cases per 1,000 CVC-days during the intervention period, and 6.4 cases per 1,000 CVC-days during the postintervention period. Table 1 shows the causative organisms by study period as well as the number of isolates per blood culture set. The percentage of polymicrobial BSIs decreased from 25% to 3% during the intervention period. We found no significant change in the case-mix index during the 3 study periods. Three of 405 patients had to discontinue the chlorhexidine applications because of generalized redness or itching; however, these were mild and reversible reactions. The results of the time-series analysis are shown in Table 2. The monthly rates of CVC-associated BSI during the preintervention period remained stable. During the intervention period, we observed a persistent decrease in the CVC-associated BSI rate of 12% per month (rate ratio, 0.88; P p
3 prevention of bsis by use of chlorhexidine baths 1033 table 1. Organisms Isolated in Culture of Samples From Patients with Central Venous Catheter Associated Bloodstream Infection, by Study Period Variable Preintervention period ( n p 59) Intervention period ( n p 29) Postintervention period ( n p 51) Pathogen CNS 30 (51) 11 (38) 20 (39) Enterococcus 12 (20) 5 (17) 12 (24) Candida 9 (15) 6 (21) 3 (6) Acinetobacter 8 (13) 2 (7) 6 (12) Pseudomonas 4 (7) 1 (3) 10 (12) Enterobacter 4(7) 0(0) 2(4) Corynebacterium 3(5) 0(0) 0(0) LF GNR 3 (5) 4 (14) 8 (16) MRSA 0 (0) 1 (3) 7 (14) Other 2 (3) 0 (0) 0 (0) No. of pathogens a 1 pathogen 44 (75) 28 (97) 36 (70) 2 pathogens 14 (23) 1 (3) 10 (20) 3 pathogens 1 (2) 0 (0) 5 (10) note. Data are no. (%) of isolates. CNS, coagulase-negative Staphylococcus; LF GNR, lactose fermentor gram-negative rod; MRSA, methicillin-resistant Staphylococcus aureus. For descriptions of the 3 different study periods and their interventions, see Methods. a Per blood culture set..02). By the end of the intervention period, there was a net reduction of 99% in the CVC-associated BSI rate. No monthly change (ie, a slope of 0) was noted during the postintervention period; rather, a change in intercept was noted, with a reduction of 33% in the rate of CVC-associated BSI, compared with during the preintervention period (rate ratio, 0.67; P p.03) (Figure). Use of mechanical ventilation influenced the BSI rates: for every 10% increase in ventilator-days in any given month, there was a 5% increase in CVC-associated BSI rates ( P!.001). No changes were seen in the incidence of VAP during the preintervention and intervention periods ( episodes per 1,000 ventilator-days). discussion LTACHs are healthcare facilities that were created to decrease the costs of acute care hospitalization while providing longterm ventilator weaning, antibiotic treatment, wound care, and physical therapy. LTACH patients are acutely ill and have multiple comorbidities. In addition, most LTACH patients have CVCs at some point during their hospital stays, 13 which puts them at high risk for developing a CVC-associated BSI. 10 During the preintervention period, we observed a CVC-associated BSI rate of 9.5 cases per 1,000 CVC-days in the LTACH under study. Unusually high rates of CVC-associated BSI in LTACHs have been described elsewhere 10 and are comparable to the 90th-percentile CVC-associated BSI rates described by the Centers for Disease Control and Prevention National Nosocomial Infection Surveillance system for intensive care units. 14 To decrease this high rate of CVC-associated BSI, we decided to bathe patients with chlorhexidine, because of the favorable results previously seen in studies of intensive care units as well as the safety data 2 and relatively low cost of this particular intervention. After implementation of chlorhexidine baths, we observed an immediate reduction in the rates of CVC-associated BSI. By the end of the intervention, there was a net reduction of 99% in the CVC-associated BSI rate. At the beginning of the intervention period, we found that constant supervision of LTACH ancillary personnel was essential to ensure that chlorhexidine baths were appropriately given. Use of additional water, potentially leading to dilution of chlorhexidine, was a frequent finding during initial inspections, although the potential impact on infection prevention is unknown. By the third month of the intervention period, the infection preventionist stopped doing regular evaluations of chlorhexidine applications. Subsequently, the infection preventionist discovered that the nursing aides were bathing patients with baby shampoo, which was then defined as the postintervention period. We were not able to quantify the proportion of patients who were bathed with baby shampoo, as opposed to chlorhexidine, during those 2 months. In October 2007, the institution implemented a corporate initiative that consisted of using daily nonmedicated disposable cleansing cloths (Comfort Baths; Sage Products) and weekly chlorhexidine baths (2% chlorhexidine gluconate cloths; Sage Products). Because of the differences in bathing procedures between the intervention period (ie, the use of chlorhexidine baths) and the subsequent, uncontrolled postintervention period, we used an interrupted time-series analysis to separate and analyze the 2 periods. Our analysis showed that, during the postintervention period, there was an increase in the rates of CVC-associated BSI, compared with the rates during the
4 1034 infection control and hospital epidemiology november 2009, vol. 30, no. 11 table 2. Multivariate Interrupted Time-Series Regression Analysis of Predictors of Rates of Central Venous Catheter Associated Bloodstream Infection in a Long-Term Acute Care Hospital Variable Full Model Reduced Model RR (95% CI) P RR (95% CI) P Month of preintervention period 1.03 ( ).71 Intervention intercept 1.07 ( ).90 Month of intervention period 0.89 ( ) ( ).02 Postintervention intercept 0.57 ( ) ( ).03 Month of postintervention period 1.06 ( ).34 % change from baseline in CMI 1.01 ( ).07 % change from baseline in ventilator-days a 1.04 (1 1.09) ( )!.001 note. CI, confidence interval; CMI, case-mix index; RR, rate ratio. The full model is a multivariate model with all initial variables included. The reduced model is the final model following backward elimination of nonsignificant covariates. For descriptions of the 3 different study periods and their interventions, see Methods. a Assessed monthly. intervention period. The evaluation of a postintervention period, in which we found the rate increase, strengthens the findings of our quasi-experimental study 15 and further validates the impact of daily chlorhexidine baths as well as the value of adherence monitoring in the prevention of CVCassociated BSIs. Patients were able to tolerate the chlorhexidine solution well, although the wound care team observed that approximately 1% of patients had increased dryness of skin. Contrary to this observation, a previous report of daily use of 2% chlorhexidine-impregnated cloths that incorporated skin emollients (Sage Products) showed an improvement in patients skin, compared with use of soap and water for bathing. 16 In addition, caution using locally prepared chlorhexidine solutions or tap water in clinical settings is needed because outbreaks associated with these preparations have been documented. 17 There are several pathways (eg, decolonization of patient skin, removal of transient flora from hands of healthcare workers who may manipulate CVCs, and decontamination of the patient s environment) 16 by which chlorhexidine cleansing may contribute to the prevention of CVC-associated BSIs. The relative impacts have not been determined, but each figure. Central venous catheter (CVC) associated bloodstream infection (BSI) rates (per 1,000 CVC-days) during the preintervention period (soap-and-water baths), the intervention period (daily 2% chlorhexidine baths), and the postintervention period (baths with baby shampoo for 3 months followed by daily baths with nonmedicated cloths and weekly baths with 2% chlorhexidine-impregnated cloths). Model-predicted rates are rates estimated by month for each time period after adjustment for ventilator use.
5 prevention of bsis by use of chlorhexidine baths 1035 potential beneficial effect of chlorhexidine may help to counteract various factors that affect the risk of CVC-associated BSI. For example, we found that ventilator use was independently associated with CVC-associated BSI, which we hypothesize may be the result of infected respiratory secretions contaminating the skin surrounding CVCs placed in the neck veins. During the chlorhexidine intervention, the decrease in CVC-associated BSI rates was independent of and additional to any benefit from changes in risk of ventilator use, and was potentially the result of decolonization of skin affected by respiratory secretions. Our study has several limitations, which were mostly due to its quasi-experimental nature and the relatively small number of patients observed. Quasi-experimental studies are by definition nonrandomized and therefore subject to confounding variables; however, the addition of a postintervention period (without chlorhexidine baths) brings more validity to our findings. 15 Also, the use of chlorhexidine started as an infection control initiative rather than as a research study, which explains why we did not do formal compliance evaluations of chlorhexidine baths. We consider that bathing patients with chlorhexidine is an easy and effective intervention that might prevent CVC-associated BSIs in LTACHs. Chlorhexidine is inexpensive (US$1 US$5 per day, depending on the specific preparation) and of the same order-of-magnitude cost as soap-and-water baths, and although we did not do a formal cost analysis, chlorhexidine bathing is most likely cost-effective when compared with the estimated cost of a CVC-associated BSI (US$3,700 US$29,000 per episode). 18 Even for budget-constrained healthcare facilities, the changes in Medicare reimbursements will further underscore the importance of implementing programs for preventing CVC-related infections. 19 We consider chlorhexidine baths a promising intervention to reduce rates of CVC-associated BSI in LTACHs. Larger and more rigorous studies are needed to generalize our findings. acknowledgments We thank Bridget Brizek, Kelly Magiera, Nancy Nimon, and Kenneth Stancik for their efforts in implementing the infection control interventions at the institution. Potential conflicts of interest. R.A.W. has served as a speaker and consultant for Sage Products. All other authors report no conflicts of interest relevant to this article. Address reprint requests to L. Silvia Munoz-Price, MD, Jackson Memorial Hospital, Park Plaza West, Room L-302, 1611 NW 12th Avenue, Miami, FL (smunozprice@med.miami.edu). Presented in part: 47th Interscience Conference on Antimicrobial Agents and Chemotherapy; Chicago, Illinois; September 17 20, 2007 (Abstract K- 1757). references 1. Klevens RM, Edwards JR, Gaynes RP. The impact of antimicrobial-resistant, health care associated infections on mortality in the United States. Clin Infect Dis 2008; 47: Bleasdale SC, Trick WE, Gonzalez IM, Lyles RD, Hayden MK, Weinstein RA. Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients. Arch Intern Med 2007; 167: Mimoz O, Villeminey S, Ragot S, et al. Chlorhexidine-based antiseptic solution vs alcohol-based povidone-iodine for central venous catheter care. Arch Intern Med 2007; 167: Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006; 355: Dematte D Amico JE, Donnelly HK, Mutlu GM, Feinglass J, Jovanovic BD, Ndukwu IM. Risk assessment for inpatient survival in the long-term acute care setting after prolonged critical illness. Chest 2003; 124: Scheinhorn DJ, Chao DC, Hassenpflug MS, Gracey DR. Post-ICU weaning from mechanical ventilation: the role of long-term facilities. Chest 2001; 120(6 Suppl):482S 484S. 7. Lusk R, O Bryan L. Evaluation of critically ill patients for transfer to long-term acute-care facilities. Lippincotts Case Manag 2002; 7: Seneff MG, Wagner D, Thompson D, Honeycutt C, Silver MR. The impact of long-term acute-care facilities on the outcome and cost of care for patients undergoing prolonged mechanical ventilation. Crit Care Med 2000; 28: Munoz-Price, L. S. Long-term acute care hospitals. Clin Infect Dis 2009; 49: Wolfenden LL, Anderson G, Veledar E, Srinivasan A. Catheter-associated bloodstream infections in 2 long-term acute care hospitals. Infect Control Hosp Epidemiol 2007; 28: Yang CM, Reinke W. Feasibility and validity of International Classification of Diseases based case mix indices. BMC Health Serv Res 2006; 6: Munoz-Price LS, Hota B, Nimon N, et al. Effect of a ventilator-associated pneumonia (VAP) infection control bundle for the prevention of VAP in a long-term care acute hospital (LTACH). In: Program and abstracts of the 18th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America (Orlando). Arlington, VA: Society for Healthcare Epidemiology of America; 2008:134. Abstract Gould CV, Rothenberg R, Steinberg JP. Antibiotic resistance in longterm acute care hospitals: the perfect storm. Infect Control Hosp Epidemiol 2006; 27: National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October Am J Infect Control 2004; 32: Shardell M, Harris AD, El-Kamary SS, Furuno JP, Miller RR, Perencevich EN. Statistical analysis and application of quasi experiments to antimicrobial resistance intervention studies. Clin Infect Dis 2007; 45: Vernon MO, Hayden MK, Trick WE, Hayes RA, Blom DW, Weinstein RA; Chicago Antimicrobial Resistance Project (CARP). Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: the effectiveness of source control to reduce the bioburden of vancomycin-resistant enterococci. Arch Intern Med 2006; 166: Romero-Gómez MP, Quiles-Melero MI, Peña García P, et al. Outbreak of Burkholderia cepacia bacteremia caused by contaminated chlorhexidine in a hemodialysis unit. Infect Control Hosp Epidemiol 2008; 29: Marschall J, Mermel LA, Classen D, et al. Strategies to prevent central line associated bloodstream infections in acute care hospitals. Infect Control Hosp Epidemiol 2008; 29(Suppl 1):S22 S Rosenthal MB. Nonpayment for performance? Medicare s new reimbursement rule. N Engl J Med 2007; 357:
CHLORHEXIDINE BATHING AND MICROBIAL CONTAMINATION IN PATIENTS BATH BASINS. Patient Safety Issues. 1.0 Hour
Patient Safety Issues CHLORHEXIDINE BATHING AND MICROBIAL CONTAMINATION IN PATIENTS BATH BASINS By Jan Powers, RN, PhD, Jennifer Peed, RN, BSN, Lindsey Burns, RN, BSN, and Mary Ziemba-Davis, BA C N E 1.0
More informationHigh Impact Intervention Central venous catheter care bundle
High Impact Intervention Central venous catheter care bundle Aim To reduce the incidence of catheter related bloodstream infection (CRBSI). Introduction The aim of the care bundle, as set out in this high
More informationCatheter-Associated Urinary Tract Infection (CAUTI) Prevention. Basics of Infection Prevention 2 Day Mini-Course 2013
Catheter-Associated Urinary Tract Infection (CAUTI) Prevention Basics of Infection Prevention 2 Day Mini-Course 2013 2 Objectives Define the scope of healthcare-associated urinary tract infections (UTI)
More informationCentral Line-Associated Bloodstream Infection (CLABSI) Prevention. Basics of Infection Prevention 2-Day Mini-Course 2013
Central Line-Associated Bloodstream Infection (CLABSI) Prevention Basics of Infection Prevention 2-Day Mini-Course 2013 2 Objectives Describe the etiology and epidemiology of central line associated bloodstream
More informationHigh Impact Intervention Care bundle to reduce ventilation-association pneumonia
High Impact Intervention Care bundle to reduce ventilation-association pneumonia Aim To reduce the incidence of ventilation-associated pneumonia (VAP). Context The aim of the care bundle, as set out in
More informationComponents of CVC Care Bundle. selection
Components of CVC Care Bundle Catheter site selection Site of insertion influences the subsequent risk for CR-BSI and phlebitis The influence of site is related in part to the risk for thrombophlebitis
More informationIntroduction to Infection Control
CHAPTER 3 Introduction to Infection Control George Byrns and Mary Elkins Learning Objectives 1 Define terms used in infection control. 2. Review significant risk factors for infection. 3. Identify the
More informationNosocomial Bloodstream infection. Khachornsakdi Silpapojakul MD Prince of Songkla University Hat yai, Thailand.
Nosocomial Bloodstream infection Khachornsakdi Silpapojakul MD Prince of Songkla University Hat yai, Thailand. Nosocomial UTI Khachornsakdi Silpapojakul MD Prince of Songkla University Hat yai, Thailand.
More informationHAI LEADERSHIP PARTNERING FOR ACCOUNTABLE CARE
HAI LEADERSHIP PARTNERING FOR ACCOUNTABLE CARE Cepheid s Government Affairs Department Advocating for Patient Access to Molecular Diagnostics in the Era of Healthcare Reform A TEAM APPROACH Legislative
More informationEAST CAROLINA UNIVERSITY INFECTION CONTROL POLICY. Methicillin-resistant Staph aureus: Management in the Outpatient Setting
EAST CAROLINA UNIVERSITY INFECTION CONTROL POLICY Methicillin-resistant Staph aureus: Management in the Outpatient Setting Date Originated: Date Reviewed: Date Approved: Page 1 of Approved by: Department
More informationManagement of Catheters Infectious Diseases Working Party/Nurses Group
Management of Catheters Infectious Diseases Working Party/Nurses Group Arno Mank RN PhD, Amsterdam (NL) www.ebmt.org London 09/04/2012 Content Background Management of CVC Types of CVC Care aspect of CVC
More informationCVC = central venous catheter. Insertion and Maintenance
Central Venous Catheter Insertion and Maintenance A Tutorial on Recommended Practices Introduction Central venous catheters (CVCs) are a commonly used modality throughout the medical center and especially
More informationESCMID Online Lecture Library. by author
Do statins improve outcomes of patients with sepsis and pneumonia? Jordi Carratalà Department of Infectious Diseases Statins for sepsis & community-acquired pneumonia Sepsis and CAP are major healthcare
More informationORTHOPAEDIC INFECTION PREVENTION AND CONTROL: AN EMERGING NEW PARADIGM
ORTHOPAEDIC INFECTION PREVENTION AND CONTROL: AN EMERGING NEW PARADIGM AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS 77th Annual Meeting March 9-12, 2010 New Orleans, Louisiana COMMITTEE ON PATIENT SAFETY PREPARED
More informationPre-operative M.R.S.A. Screening Information for Patients
Infection Prevention and Control Pre-operative M.R.S.A. Screening Information for Patients This information is designed for patients undergoing MRSA screening before coming into hospital for a planned
More informationTranslating Evidence to Safer Care Patient Safety Research Introductory Course Session 7 Albert W Wu, MD, MPH Former Senior Adviser, WHO Professor of Health Policy & Management, Johns Hopkins Bloomberg
More informationLab ID Events MRSA Bloodstream Infection and C. difficile
Lab ID Events MRSA Bloodstream Infection and C. difficile MDRO and CDI Module Methicillin-resistant Staphylococcus (MRSA), Vancomycinresistant Enterococcus(VRE), certain gram negative bacilli, Clostridium
More informationAPIC Position Paper: The Importance of Surveillance Technologies in the Prevention of Healthcare-Associated Infections (HAIs)
1275 K Street, NW, Suite 1000 Washington, DC 20005-4006 Phone: 202/789-1890 Fax: 202/789-1899 apicinfo@apic.org www.apic.org APIC Position Paper: The Importance of Surveillance Technologies in the Prevention
More informationHialeah Nursing and Rehabilitation Center Combines Technology and Best Practices to Improve Infection Control Specific to C.diff
RESEARCH ARTICLE Page 1 of 5 Hialeah Nursing and Rehabilitation Center Combines Technology and Best Practices to Improve Infection Control Specific to C.diff ABSTRACT RB Health Partners, Inc., June 24,
More informationHemodialysis catheter infection
Hemodialysis catheter infection Scary facts In 2006, 82% of patients in the United States initiated dialysis via a catheter The overall likelihood of Tunneled cuffed catheters use was 35% greater in 2005
More informationC-Difficile Infection Control and Prevention Strategies
C-Difficile Infection Control and Prevention Strategies Adrienne Mims, MD MPH VP, Chief Medical Officer Adrienne.Mims@AlliantQuality.org 1/18/2016 1 Disclosure This educational activity does not have commercial
More informationb. Povidone Iodine 5% Swabsticks, Single Pack (4 packs) c. Clean gloves
Program Agenda SUBJECT: Universal Decolonization Protocols for Pre-operative Orthopedic Patients EFFECTIVE DATE: 5/2014 REVISED DATE: I. Policy: The largest fraction of hospital acquired infections (HAIs),
More informationRecommendations for Metrics for Multidrug-Resistant Organisms in Healthcare Settings: SHEA/HICPAC Position Paper
infection control and hospital epidemiology october 2008, vol. 29, no. 10 shea/hicpac position paper Recommendations for Metrics for Multidrug-Resistant Organisms in Healthcare Settings: SHEA/HICPAC Position
More informationMean Duration (days) ± SD b. n = 587 n = 587
Online Table 1. Length of stay in matched cohorts of patients with VA and patients without VA a MS-DRG opulation (Code) ECMO or tracheostomy with mechanical ventilation 96 hours or principal diagnosis
More informationKi m b e r l y-cl a r k* 72-Hour Closed-Suction Systems. Ba l l a r d* Tr a c h Ca r e* System. A unique design. A new standard in clean.
Ki m b e r l y-cl a r k* 72-Hour Closed-Suction Systems Ba l l a r d* Tr a c h Ca r e* System A unique design. A new standard in clean. Ki m b e r l y-cl a r k* 72-Hour Closed-Suction Systems Ba l l a
More informationAddressing the challenge of healthcare associated infections (HCAIs) in Europe
POSITION PAPER 05 January 2011 Addressing the challenge of healthcare associated infections (HCAIs) in Europe A Call for Action Page 1 of 8 A holistic approach to combating HCAIs in Europe We must rise
More informationSpotlight on Success: Implementing Nurse-Driven Protocols to Reduce CAUTIs
Spotlight on Success: Implementing Nurse-Driven Protocols to Reduce CAUTIs Many hospitals today are increasingly allowing nurses to make decisions regarding patients care, treatment, and services without
More informationMedicare Long-Term Care Hospital Prospective Payment System
Medicare Long-Term Care Hospital Prospective Payment System May 5, 2015 Payment Rule Brief PROPOSED RULE Program Year: FFY 2016 Overview, Resources, and Comment Submission On May 17, the Centers for Medicare
More informationChronic Critical Illness: Can it be prevented? Carmen C Polito, MD Pulmonary & Critical Care Medicine Emory University Atlanta, GA cpolito@emory.
Chronic Critical Illness: Can it be prevented? Carmen C Polito, MD Pulmonary & Critical Care Medicine Emory University Atlanta, GA cpolito@emory.edu Data free zone Disclosures A (Very) Old Case 65 year-old
More informationNURSE DRIVEN FOLEY CATHETER PROTOCOL
NURSE DRIVEN FOLEY CATHETER PROTOCOL BACKGROUND There are over 1.7 million hospital-acquired infections in US hospitals annually, 40% of which are urinary tract infections. 80% of hospital-acquired UTIs
More informationMN HAI Prevention Plan 1
Healthcare Associated Infections Plan Minnesota Department of Health Healthcare Associated Infections Program Introduction In response to the increasing concerns about the public health impact of healthcare-associated
More informationassociated Urinary Tract Infection Case Definitions
CDC/NHSN Cather-associated associated Urinary Tract Infection Case Definitions Chaz M. Rhone, MPH Regional HAI Epidemiologist Florida Department of Health *all information is directly from the NHSN site
More informationJune 10, 2015. Dear Mr. Slavitt:
1275 K Street, NW, Suite 1000 Washington, DC 20005-4006 Phone: 202/789-1890 Fax: 202/789-1899 apicinfo@apic.org www.apic.org June 10, 2015 Andrew M. Slavitt Acting Administrator Centers for Medicare &
More informationPATIENT GUIDE. Understand and care for your peripherally inserted central venous catheter (PICC). MEDICAL
PATIENT GUIDE Understand and care for your peripherally inserted central venous catheter (PICC). MEDICAL Introduction The following information is presented as a guideline for your reference. The best
More informationVUMC Guidelines for Management of Indwelling Urinary Catheters. UC Access/ Maintenance
VUMC Guidelines for Management of Indwelling Urinary Catheters UC Insertion Preparation & Procedure Indications for insertion and continued use of indwelling urinary catheters include: Urinary retention
More informationWelcome and Instructions
Welcome and Instructions For audio, join by telephone at 877-594-8353, participant code: 56350822 Your line is OPEN. Please do not use the hold feature on your phone but do mute your line by dialing *6.
More informationVaxcel PICCs Valved and Non-Valved. A Patient s Guide
Vaxcel PICCs Valved and Non-Valved A Patient s Guide Information about your Vaxcel PICC is available by calling the Navilyst Medical Vascular Access Information Line 800.513.6876 Vaxcel Peripherally Inserted
More informationPolicies & Procedures. I.D. Number: 1073
Policies & Procedures Title:: CENTRAL VENOUS CATHETERS INSERTION ASSISTING I.D. Number: 1073 Authorization [] Pharmacy Nursing Committee [] MAC Motion #: [x] SHR Nursing Practice Committee Source: Nursing
More informationObjective. Suggested Reading: WHO Aide-Memoire: Hand Hygiene How to Hand Rub / How to Hand Wash Poster. Hand out/materials See activities
Hand Hygiene Objective Objectives Demonstrate correct Hand Hygiene technique Knowledge of multi-faceted plans to improve hand hygiene Understand appropriate Hand Hygiene practices when caring for patient
More informationPatient Safety: Applying Industrial Quality Models in Healthcare Settings Tempora mutantur, nos et mutamur in illis
Patient Safety: Applying Industrial Quality Models in Healthcare Settings Tempora mutantur, nos et mutamur in illis Julie Louise Gerberding, MD MPH Division of Healthcare Quality Promotion National Center
More informationYale New Haven Health System Center for Healthcare Solutions
Table of Contents Education and Training Yale New Haven Health System Center for Healthcare Solutions 2009-2010 Fall/Winter Course Guide TOPICS center@ynhh.org www.yalenewhavenhealth.org/healthcaresolutions
More information2013 Indiana Healthcare Provider and Hospital Administrator Multi-Drug Resistant Organism Survey
2013 Indiana Healthcare Provider and Hospital Administrator Multi-Drug Resistant Organism Survey Antibiotic resistance is a global issue that has significant impact in the field of infectious diseases.
More informationVRE. Living with. Learning how to control the spread of Vancomycin-resistant enterococci (VRE)
VRE Living with Learning how to control the spread of Vancomycin-resistant enterococci (VRE) CONTENTS IMPORTANT VRE is a serious infection that may become life-threatening if left untreated. If you or
More informationINFECTION CONTROL PRECAUTIONS
INFECTION CONTROL PRECAUTIONS Outline Standard Precautions Droplet Precautions Contact Precautions Airborne Precautions References STANDARD PRECAUTIONS Use Standard Precautions, or the equivalent, for
More informationState HAI Template Utah. 1. Develop or Enhance HAI program infrastructure
State HAI Template Utah 1. Develop or Enhance HAI program infrastructure Successful HAI prevention requires close integration and collaboration with state and local infection prevention activities and
More informationRisk Adjustment for Healthcare Facility-Onset C. difficile and MRSA Bacteremia Laboratory-identified Event Reporting in NHSN
Risk Adjustment for Healthcare Facility-Onset C. difficile and MRSA Bacteremia Laboratory-identified Event Reporting in NHSN Margaret A. Dudeck, MPH, CPH, Lindsey M. Weiner, MPH, Paul J. Malpiedi, MPH,
More informationHealth-Care Associated Infection Rates among Adult Patients in Bahrain Military Hospital: A Cross Sectional Survey
Bahrain Medical Bulletin, Vol. 32, No. 1, March 2010 Health-Care Associated Infection Rates among Adult Patients in Bahrain Military Hospital: A Cross Sectional Survey Kelechi Austin Ofurum, M.Sc, B.Sc*,
More informationMassachusetts Department of Developmental Services MRSA, VRE, and C. Diff Management Protocol
Massachusetts Department of Developmental Services MRSA, VRE, and C. Diff Management Protocol PURPOSE: To provide guidance for personnel in order to prevent the spread of Antibiotic Resistant Microorganisms
More information5/29/2014. Infection Control in the NICU. Objectives. The Babies. Terrence Shenfield BS RRT/RPFT/NPS Education Coordinator University Hospital
Infection Control in the NICU Terrence Shenfield BS RRT/RPFT/NPS Education Coordinator University Hospital Objectives Discuss nosocomial infections in the NICU Device acquired infections Ventilator Associated
More informationNorth Carolina Statewide Program for Infection Control and Prevention (SPICE) Objectives. Healthcare-Associated Infections: Impact
North Carolina Statewide Program for Infection Control and Prevention (SPICE) Karen K. Hoffmann, RN, MS, CIC, FSHEA U School of Medicine, Chapel Hill, NC Objectives Describe how and why SPICE was created.
More informationA novel educational programme to improve knowledge regarding health care-associated infection and hand hygieneijn_1934 269..274
International Journal of Nursing Practice 2011; 17: 269 274 RESEARCH PAPER A novel educational programme to improve knowledge regarding health care-associated infection and hand hygieneijn_1934 269..274
More informationPeripherally Inserted Central Catheter (PICC)
Peripherally Inserted Central Catheter (PICC) Disclaimer This is general information developed by The Ottawa Hospital. It is not intended to replace the advice of a qualified healthcare provider. Please
More informationPCORnet Use Cases. Cluster randomized trial: Routine decolonization of non-icu medical surgical patients to prevent healthcare associated infections
PCORnet Use Cases Cluster randomized trial: Routine decolonization of non-icu medical surgical patients to prevent healthcare associated infections 1 Susan Huang, MD MPH University of California, Irvine
More informationINFECTION CONTROL AND PREVENTION STRATEGY AND ACTION PLAN
INFECTION CONTROL AND PREVENTION STRATEGY AND ACTION PLAN ORIGINATOR Control of Infection DATE April 2005 APPROVED BY Trust Board Policy ID: 281 DATE OF REVIEW April 2008 BRO MORGANNWG NHS TRUST INFECTION
More informationJune 25, 2012. Dear Acting Administrator Tavenner,
June 25, 2012 Marilyn B. Tavenner, RN, Acting Administrator Centers for Medicare and Medicaid Services Department of Health and Human Services Attention: CMS-1588-P P.O. Box 8011 Baltimore, MD 21244-1850
More informationAPIC Practice Guidance Committee: Implementation Insights Prevention & Control of Pertussis
1275 K Street, NW, Suite 1000 Washington, DC 20005-4006 Phone: 202/789-1890 Fax: 202/789-1899 apicinfo@apic.org www.apic.org APIC Practice Guidance Committee: Implementation Insights Prevention & Control
More informationA Comparison of Costs Between Medical and Surgical Patients in an Academic Pediatric Intensive Care Unit
ORIGINAL RESEARCH A Comparison of Costs Between Medical and Surgical Patients in an Academic Pediatric Intensive Care Unit Benson S. Hsu, MD, MBA; Thomas B. Brazelton III, MD, MPH ABSTRACT Objective: To
More informationNursing college, Second stage Microbiology Dr.Nada Khazal K. Hendi L14: Hospital acquired infection, nosocomial infection
L14: Hospital acquired infection, nosocomial infection Definition A hospital acquired infection, also called a nosocomial infection, is an infection that first appears between 48 hours and four days after
More informationAppendix 1: Detailed Summary of Systematic Review
Appendix 1: Detailed Summary of Systematic Review Study, Feature Score,, Data Safety Improvement Cohort and Time Horizon for Main Outcome Measures and Case Adverse Drug Events (ADEs) Karnon 2009 [1] feature
More informationBusiness Case for National Healthcare Safety Network (NHSN) Infection Surveillance Database
Business Case for National Healthcare Safety Network (NHSN) Infection Surveillance Database Executive Summary All hospitals understand the value of preventing healthcare-associated infections (HAIs) and
More informationRaoult Ratard, MD, MS, MPH Louisiana State Epidemiologist. Debra Rushing, RN, MBA/HCM, CPE Executive Director eqhealth Solutions Louisiana
Raoult Ratard, MD, MS, MPH Louisiana State Epidemiologist Debra Rushing, RN, MBA/HCM, CPE Executive Director eqhealth Solutions Louisiana Erica Washington, MPH Healthcare-Associated Infections Coordinator
More informationUnited States Government Accountability Office March 2008 GAO-08-283
GAO United States Government Accountability Office Report to the Chairman, Committee on Oversight and Government Reform, House of Representatives March 2008 HEALTH-CARE- ASSOCIATED INFECTIONS IN HOSPITALS
More informationInfection Prevention
Infection Prevention Dear HSS Patient: The Hospital for Special Surgery is committed to patient safety and quality patient care and is proud to have achieved one of the lowest infection rates in New York
More informationI. Questions for VAD slide program
I. Questions for VAD slide program 1. The rate of central line associated blood stream infections (CLABSI) in the adult ICUs in Johns Hopkins Hospital is lower than the national average. 2. The mortality
More informationBig Data Health Big Health Improvements? Dr Kerry Bailey MBBS BSc MSc MRCGP FFPH Dr Kelly Nock MPhys PhD
Big Data Health Big Health Improvements? Dr Kerry Bailey MBBS BSc MSc MRCGP FFPH Dr Kelly Nock MPhys PhD Epidemiology Infection 2006 Dec;134(6):1167-73. Epub 2006 Apr 20. Risk factors for hospital-acquired
More informationPolicy for Screening Patients for MRSA Colonisation
Policy for Screening Patients for MRSA Colonisation To whom this document applies: All staff in Colchester Hospital University Foundation Trust screening Patients for MRSA Procedural Documents Approval
More informationIatrogenesis. Suzanne Beyea,, RN, PhD, FAAN Associate Director: Centers for Health and Aging
Iatrogenesis Suzanne Beyea,, RN, PhD, FAAN Associate Director: Centers for Health and Aging Iatrogenesis Definition from the Greek word, iatros,, meaning healer, iatrogenesis means brought forth by a healer
More informationCatheter-Associated Urinary Tract Infection (CAUTI) Event
Catheter-Associated Urinary Tract Infection () Event Introduction: Urinary tract infections (UTIs) are tied with pneumonia as the second most common type of healthcare-associated infection, second only
More informationWritten Statement. for the. Senate Finance Committee of The United States
Written Statement of Isis Montalvo, RN, MS, MBA Manager, Nursing Practice & Policy American Nurses Association 8515 Georgia Avenue, Suite 400 Silver Spring, MD 20903 for the Senate Finance Committee of
More informationBIBLIOGRAPHICAL REVIEW ON COST OF PATIENT SAFETY FAILINGS IN NOSOCOMIAL INFECTIONS. SUMMARY.
BIBLIOGRAPHICAL REVIEW ON COST OF PATIENT SAFETY FAILINGS IN NOSOCOMIAL INFECTIONS. SUMMARY. Bibliographical review on cost of Patient Safety Failings in nosocomial s. Summary This study has been conducted
More informationOverview of the Hospital Value-Based Purchasing (VBP) Fiscal Year (FY) 2017
Overview of the Hospital Value-Based Purchasing (VBP) Fiscal Year (FY) 2017 Bethany Wheeler Hospital VBP Program Support Contract Lead HSAG February 17, 2015 2 p.m. ET Purpose This event will provide an
More informationhealthcare associated infection 1.2
healthcare associated infection A C T I O N G U I D E 1.2 AUSTRALIAN SAFETY AND QUALITY GOALS FOR HEALTH CARE What are the goals? The Australian Safety and Quality Goals for Health Care set out some important
More informationRoot Cause Analysis following
Root Cause Analysis following MRSA Bacteraemia: Reviewing the Patient s Journey Sharren Pells Senior Infection Control Nurse NHS Swindon Helen Forrest Infection Control Nurse Specialist NHS Swindon Aims
More informationAntibiotic Lock Therapy Guideline
Antibiotic Lock Therapy Guideline I. PURPOSE Central venous catheters are an integral part in medical management for patients requiring long-term total parenteral nutrition, chemotherapy, or hemodialysis,
More informationManagement of Extended Spectrum Beta- Lactamase (ESBL) Producing Enterobacteriaceae in health care settings
Management of Extended Spectrum Beta- Lactamase (ESBL) Producing Enterobacteriaceae in health care settings Dr. Mary Vearncombe PIDAC-IPC February 2012 Objectives: To provide an overview of the RP/AP Annex
More informationAre venous catheters safe in terms of blood tream infection? What should I know?
Are venous catheters safe in terms of blood tream infection? What should I know? DIAGNOSIS, PREVENTION AND TREATMENT OF HAEMODIALYSIS CATHETER-RELATED BLOOD STREAM INFECTIONS (CRBSI): A POSITION STATEMENT
More informationStaphylococcus aureus Bloodstream Infection Treatment Guideline
Staphylococcus aureus Bloodstream Infection Treatment Guideline Purpose: To provide a framework for the evaluation and management patients with Methicillin- Susceptible (MSSA) and Methicillin-Resistant
More informationSepsis: Identification and Treatment
Sepsis: Identification and Treatment Daniel Z. Uslan, MD Associate Clinical Professor Division of Infectious Diseases Medical Director, UCLA Sepsis Task Force Severe Sepsis: A Significant Healthcare Challenge
More informationValue-Based Purchasing Program Overview. Maida Soghikian, MD Grand Rounds Scripps Green Hospital November 28, 2012
Value-Based Purchasing Program Overview Maida Soghikian, MD Grand Rounds Scripps Green Hospital November 28, 2012 Presentation Overview Background and Introduction Inpatient Quality Reporting Program Value-Based
More informationGuy s, King s and St Thomas Cancer Centre The Cancer Outpatient Clinic Central venous catheter: Peripherally inserted central catheter
Guy s, King s and St Thomas Cancer Centre The Cancer Outpatient Clinic Central venous catheter: Peripherally inserted central catheter This information leaflet aims to help answer some of the questions
More informationThe Vermont Healthcare Associated Infection Prevention Plan
The Vermont Healthcare Associated Infection Prevention Plan Submitted to the Centers for Disease Control and Prevention on January 1, 2010 This plan was developed through a collaborative effort of the
More informationAmbient air contamination with Acinetobacter baumannii on consecutive. inpatient days
JCM Accepted Manuscript Posted Online 29 April 2015 J. Clin. Microbiol. doi:10.1128/jcm.00198-15 Copyright 2015, American Society for Microbiology. All Rights Reserved. 1 2 Ambient air contamination with
More informationPrevention and control of infection in care homes. Summary for staff
Prevention and control of infection in care homes Summary for staff 1 DH INFORMATION READER BOX Policy Clinical Estates HR / Workforce Commissioner Development IM & T Management Provider Development Finance
More informationA. Sue Carlisle, PhD, MD Professor of Anesthesia and Medicine Associate Dean for UCSF at SFGH
A. Sue Carlisle, PhD, MD Professor of Anesthesia and Medicine Associate Dean for UCSF at SFGH VIEW FROM 23RD STREET 10 10 100,000 individuals seen/year 600,000 outpatient visits 16,500 admissions 6000
More informationOpen and Honest Care in your Local Hospital
Open and Honest Care in your Local Hospital The Open and Honest Care: Driving Improvement Programme aims to support organisations to become more transparent and consistent in publishing safety, experience
More informationAdministrative Data Fail to Accurately Identify Cases of Healthcare-Associated Infection
infection control and hospital epidemiology april 2006, vol. 27, no. 4 original article Administrative Data Fail to Accurately Identify Cases of Healthcare-Associated Infection Eileen R. Sherman, MS; Kateri
More informationZERO By Chris Abe, RN, BSN, CIC, HEM; Jeanne Zack, PhD(c), RN, CIC; Stephen R. Lewis, MD; Tim Vanderveen, PharmD, MS
ZERO Photos courtesy of Cardinal Health By Chris Abe, RN, BSN, CIC, HEM; Jeanne Zack, PhD(c), RN, CIC; Stephen R. Lewis, MD; Tim Vanderveen, PharmD, MS 14 Patient Safety & Quality Healthcare November/December
More informationMethicillin Resistant Staphylococcus aureus (MRSA) in Tasmanian Rural Hospitals and Non Acute Health Settings
Methicillin Resistant Staphylococcus aureus (MRSA) in Tasmanian Rural Hospitals and Non Acute Health Settings Guidance for the management of patients with MRSA in Tasmania's rural hospitals and non acute
More informationMRSA Positive. An information guide
TO PROVIDE THE VERY BEST CARE FOR EACH PATIENT ON EVERY OCCASION MRSA Positive An information guide MRSA Positive What is MRSA? Staphylococcus aureus is a germ often found on the skin and up the nose of
More informationImproving Appropriate Use of Proton Pump Inhibitors as Gastrointestinal Prophylaxis in the Hospital Setting
Improving Appropriate Use of Proton Pump Inhibitors as Gastrointestinal Prophylaxis in the Hospital Setting DATE Educating for Quality Improvement & Patient Safety 1 The Team Division CS&E Participants
More informationReducing Barriers, Enforcing Standards, and Providing Incentives to Immunize
Reducing Barriers, Enforcing Standards, and Providing Incentives to Immunize Institute of Medicine National Vaccine Plan Meeting: Goal 4 July 24, 2008 Chicago, Illinois Lance E Rodewald, MD Immunization
More informationUrinary Tract Infections
Urinary Tract Infections Leading cause of morbidity and health care expenditures in persons of all ages. An estimated 50 % of women report having had a UTI at some point in their lives. 8.3 million office
More informationTHE EFFECTS OF NURSE EDUCATION AND CERTIFICATION ON HOSPITAL- ACQUIRED INFECTIONS
THE EFFECTS OF NURSE EDUCATION AND CERTIFICATION ON HOSPITAL- ACQUIRED INFECTIONS Cassi Welch, BSN Honors Student Faculty Mentor: Emily Cramer, PhD Submitted to the University of Kansas School of Nursing
More informationSafety FIRST: Infection Prevention Tips
Reading Hospital Safety FIRST: Infection Prevention Tips Reading Hospital is committed to providing high quality care to our patients. Your healthcare team does many things to help prevent infections.
More informationObjective 1A: Increase the adoption and effective use of health IT products, systems, and services
1275 K Street, NW, Suite 1000 Washington, DC 20005-4006 Phone: 202/789-1890 Fax: 202/789-1899 apicinfo@apic.org www.apic.org February 4, 2015 Karen DeSalvo, MD, MPH, MSc National Coordinator for Health
More informationCatheter-associated Urinary Tract Infection (CAUTI) Toolkit
Activity C: ELC Prevention Collaboratives Catheter-associated Urinary Tract Infection (CAUTI) Toolkit Carolyn Gould, MD MSCR Division of Healthcare Quality Promotion Centers for Disease Control and Prevention
More informationArizona Department of Health Services State Healthcare-Associated Infection Plan
Executive Summary Healthcare-associated infections (HAI) are an emerging public health issue and have received increasing public attention. Arizona healthcare facilities and infection preventionists at
More informationUnderstanding your Peripherally Inserted Central Catheter (PICC) Patient Information
Understanding your Peripherally Inserted Central Catheter (PICC) Patient Information The Purpose of this Information Sheet This information sheet has been written by patients, members of the public and
More informationPeripherally Inserted Central Catheter
Peripherally Inserted Central Catheter (PICC) by Patricia Griffin Kellicker, BSN En Español (Spanish Version) Definition A peripherally inserted central catheter is a long, thin tube that is inserted through
More informationReport by the Comptroller and Auditor General. The Management and Control of Hospital Acquired Infection in Acute NHS Trusts in England
Report by the Comptroller and Auditor General The Management and Control of Hospital Acquired Infection in Acute NHS Trusts in England HC 230 Session 1999-00 17 February 2000 Report by the Comptroller
More information